Why the study?
Cardiotoxicity limits the use of doxorubicin in cancer treatment, prompting evaluation of whether the antioxidant N-acetylcysteine can protect against doxorubicin-induced cardiotoxicity.
Does N-acetylcysteine prevent doxorubicin-induced cardiotoxicity in adult male albino rats?
Population
Forty adult male albino rats
Comparison
DOX plus NAC vs DOX alone vs controls (saline or NAC alone)
Design
Preclinical animal study
Authors
Loading...
Promising in rat model; leaves open clinical translation and requires human trials.
Does N-acetylcysteine prevent doxorubicin-induced cardiotoxicity in adult male albino rats?
N-acetylcysteine demonstrates a protective effect against doxorubicin-induced cardiotoxicity in a rat model, suggesting potential as a cardioprotective agent.
Mostafa et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: